Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Jason Roberts BPharm (Hons), PhD

Prof. Jason Roberts BPharm (Hons), PhD

Clinical Pharmacist, Royal Brisbane and Women’s Hospital; Australian National Health and Medical Research Council Leadership Fellow, The University of Queensland, Queensland, Australia

Professor Jason Roberts is a Clinical Pharmacist at Royal Brisbane and Women’s Hospital and an Australian National Health and Medical Research Council Leadership Fellow at The University of Queensland. He is Acting Director of the University of Queensland Centre for Clinical Research as well as Interim Director of the Herston Infectious Diseases Institute (HeIDI). He also leads the Centre of Research Excellence RESPOND which aims to develop optimised antibiotic dosing regimens to improve patient outcomes and minimise the emergence of antibiotic-resistant superbugs.

Disclosures

Consultancies/Advisory Boards – Qpex (2022); Gilead (2022); Advanz Pharma (2022); Pfizer (2020); Sandoz (2020); Wolters Kluwer (2021); MSD (2019); Summit Pharma (2021)
Speaking Fees– Pfizer (2023); MSD (2022); Gilead (2022); Cipla (2021)
Industry Grants – Pfizer (2023); QPEX (2021), British Society of Antimicrobial Chemotherapy (2021); Biomerieux (2019)